RxDoctor Payments Data

Baldassarre Stea, MD

Radiation Oncology · Tucson, AZNPI 1003988247

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. GT Medical Technologies, Inc accounts for 60.2% of it on its own, with 14 other manufacturers making up the rest.

$10,056in general payments, 2019–2025

Across 66 payments — averaging $152.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GT Medical Technologies, Inc$6K
  • Siemens Medical Solutions USA, Inc.$929
  • Viewray Technologies Inc$853
  • Elekta, Inc.$559
  • Varian Medical Systems, Inc.$486
  • Brainlab, Inc.$309
  • plus $865 from 9 others
$110,307in research payments, 2019–2025

Across 44 payments — averaging $2506.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novocure GmbH$110K

What the payments were for

  • Consulting fees$1,00010%
  • Travel & lodging$3,29633%
  • Food & beverage$5,76057%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,056 in reported general payments places this provider in the 85th percentile of 138 radiation oncology providers in Arizona.

See all radiation oncology providers in Arizona

Medicare billing

Part B allowed, 2024
$49,984
Medicare patients
103
Services billed
520

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →